ENTR - Enterprise and Industry DG
The Transparency Committee is a consultative Committee established by Article 10 of Directive 89/105/EEC relating to the Transparency of measures regulating the pricing of medicinal products and their inclusion in the scope of national health insurance systems (OJ N°40 of 11.2.1989, p. 8). Its main mission is to discuss issues relating to the application of the directive, including any question brought up by the Commission or at the request of a Member State.
Coordinates with Member States, exchange of views
Provides expertise to the Commission when preparing implementing measures, i.e. before the Commission submits these draft measures to a comitology committee
Third Country (Public affairs, Public health), Candidate country (Public health), National administrations